Volume 5, Issue 4 (November 2018)                   IJML 2018, 5(4): 237-245 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gharibi S, Moghimi B, Tahoori M, Mahmoudi M, Shahvazian E, Farashahi Yazd E. The miR-223: An Inflammatory MicroRNA Involved in Pathogenesis of Multiple Sclerosis. IJML. 2018; 5 (4) :237-245
URL: http://ijml.ssu.ac.ir/article-1-240-en.html
Genetic Engineering and Genome Editing Laboratory, Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract:   (116 Views)
Multiple sclerosis (MS) is the most common autoimmune inflammatory demyelinating disease that affects the brain and spinal cord. Dysregulation or mutation of miRNA genes have been linked to the pathogenesis of MS. The miRNAs are short, 20-22 nucleotide long, single-stranded regulatory and non-protein coding RNAs that modulate the expression of multiple target genes. Among miRNAs, miR-223 has been reported to play a critical role in MS. This review concentrates on the emerging role of miR-223 in inflammatory responses and specifically discusses how alterations in miR-223 expression are associated with the development of MS. This review also suggests that miR-223 can be used as a biomarker for diagnosis of MS and discovering novel therapeutics for MS treatment.
Full-Text [PDF 415 kb]   (42 Downloads) |   |   Full-Text (HTML)  (4 Views)  
Type of Study: Research | Subject: Genetics/ Biotechnology
Received: 2018/05/26 | Accepted: 2018/10/8 | Published: 2018/11/27

Add your comments about this article : Your username or Email:
CAPTCHA code

© 2018 All Rights Reserved | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb